Share |

machine learning

Dr. David Brown: How Viagra opened the doors to machine learning innovation

March 17, 2023

In an exclusive interview with Campden FB, Dr. David Brown talks about his passion for entrepreneurialism, the mind-blowing benefits of machine learning and how big pharma needs a change in mindset…

Throughout his storied career, Dr. David Brown has made significant contributions to medical research within the pharmaceutical industry, but perhaps his most famous innovation came about through a chance observation when the angina medication he was working on had unexpected applications.

While working for Pfizer, he was named co-inventor on the patent for Viagra and, for eight years, led the team that developed the hugely successful erectile dysfunction medication into one of the bonanza breakthroughs of the century.

Family office participation in venture capital slows down in the wake of global turmoil

January 30, 2023

With rising volatility in public markets, geopolitical uncertainty and higher inflation, the second half of 2022 saw family office interest in venture capital investing slow significantly, according to Campden Wealth and SVB Capital’s Family Offices Investing in Venture Capital Report.

With rising volatility in public markets, geopolitical uncertainty and higher inflation, the second half of 2022 saw family office (FO) interest in venture capital (VC) investing slow significantly.

Beyond the promise of AI in healthcare: How well does the bear dance?

July 4, 2022

Artificial intelligence and machine learning are both terms that have become murky through over-use and misuse. Investors are increasingly sceptical of companies claiming their technology is powered by AI, says Gabriel Douville, principal of Sectoral Asset Management Inc.

Artificial intelligence (AI) and machine learning (ML) are both terms that have become murky through over-use and misuse. Investors are increasingly sceptical of companies claiming their technology is powered by AI.

They question if, in fact, the promised mechanics are little more than computer-driven automation or merely standard multiple, or even single, linear regressions. Deeper investigation often reveals the software does not begin to approach sophisticated ML or deep-learning (DL) algorithms.

Medtronic leverages reach to commercialise partner products in growth markets

October 6, 2021

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

We are pleased to report that in our mission to alleviate pain, restore health and extend life, we have had a positive impact on more than 72 million patients during the year despite pandemic-related challenges.

Matthew Salloway on venture capital, technology startups and investing across North America, the Middle East and Japan

May 14, 2021

Leading venture capitalist Matthew Salloway is on the hunt for innovative technology startups on behalf of his family office and fund and says the 5G economy is a 15 trillion-dollar economic opportunity.

Salloway is the chief executive of GSI Ventures, a top 50 Global Family Office, with a focus on venture capital and portfolio market expansion into the Middle East and North Africa region. He is also the co-founder and managing partner of SIP Global Partners, an international performance venture fund investing in global technology companies.